APA (7th ed.) Citation

Li, L. Disproportionate adverse event signals of selumetinib in neurofibromatosis type I: Insights from FAERS. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Li, Lin. Disproportionate Adverse Event Signals of Selumetinib in Neurofibromatosis Type I: Insights from FAERS. Frontiers Media S.A.

MLA (9th ed.) Citation

Li, Lin. Disproportionate Adverse Event Signals of Selumetinib in Neurofibromatosis Type I: Insights from FAERS. Frontiers Media S.A.

Warning: These citations may not always be 100% accurate.